In relevant studies, the inhibition of the PI3K/AKT/mTOR signaling pathway has been demonstrated to decrease the expression levels of glycolytic enzymes, leading to apoptosis and restoring chemotherapy sensitivity in cancer cells by reducing ATP energy production, which ultimately improves patient prognosis 15. This evidence concerns the gene AKT1 and cancer.